Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Clinical and Experimental Immunology
|
June 26, 2022
Risk stratification through allergy history: single-centre experience of specialized COVID-19 vaccine clinic
Daniel Lyons, Cliodhna Murray, Siobhan Hannigan, et al.
Journal of Clinical Immunology
|
May 23, 2022
Inborn Errors of Immunity on the Island of Ireland - a Cross-Jurisdictional UKPID/ESID Registry Report
Paul Ryan, Vyanka Redenbaugh, Jayne McGucken, et al.
Journal of Clinical Immunology
|
June 22, 2022
Correction to: Inborn Errors of Immunity on the Island of Ireland - a Cross‑Jurisdictional UKPID/ESID Registry Report
Paul Ryan, Vyanka Redenbaugh, Jayne McGucken, et al.
The Journal of Allergy and Clinical Immunology
|
April 5, 2014
Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndrome
Sven Kracker, James Curtis, Mohammad A A Ibrahim, et al.
Molecular & Cellular Proteomics : MCP
|
July 16, 2008
Identification of diagnostic biomarkers for infection in premature neonates
Stephen F Kingsmore, Neil Kennedy, Henry L Halliday, et al.
The Journal of Allergy and Clinical Immunology
|
January 26, 2019
Combined liver and hematopoietic stem cell transplantation in patients with X-linked hyper-IgM syndrome
Giorgia Bucciol, Sarah K Nicholas, Pier Luigi Calvo, et al.
Journal of Clinical Immunology
|
November 26, 2015
The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1
Mark Depner, Sebastian Fuchs, Jan Raabe, et al.
The World Allergy Organization Journal
|
April 3, 2019
X-linked agammaglobulinemia (XLA):Phenotype, diagnosis, and therapeutic challenges around the world
Zeinab A El-Sayed, Irina Abramova, Juan Carlos Aldave, et al.
The Journal of Allergy and Clinical Immunology
|
August 25, 2016
Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study
Tanya I Coulter, Anita Chandra, Chris M Bacon, et al.
Frontiers in Immunology
|
March 31, 2018
Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry
Maria Elena Maccari, Hassan Abolhassani, Asghar Aghamohammadi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Clinical and Experimental Immunology
|
June 26, 2022
Risk stratification through allergy history: single-centre experience of specialized COVID-19 vaccine clinic
Daniel Lyons, Cliodhna Murray, Siobhan Hannigan, et al.
Journal of Clinical Immunology
|
May 23, 2022
Inborn Errors of Immunity on the Island of Ireland - a Cross-Jurisdictional UKPID/ESID Registry Report
Paul Ryan, Vyanka Redenbaugh, Jayne McGucken, et al.
Journal of Clinical Immunology
|
June 22, 2022
Correction to: Inborn Errors of Immunity on the Island of Ireland - a Cross‑Jurisdictional UKPID/ESID Registry Report
Paul Ryan, Vyanka Redenbaugh, Jayne McGucken, et al.
The Journal of Allergy and Clinical Immunology
|
April 5, 2014
Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndrome
Sven Kracker, James Curtis, Mohammad A A Ibrahim, et al.
Molecular & Cellular Proteomics : MCP
|
July 16, 2008
Identification of diagnostic biomarkers for infection in premature neonates
Stephen F Kingsmore, Neil Kennedy, Henry L Halliday, et al.
The Journal of Allergy and Clinical Immunology
|
January 26, 2019
Combined liver and hematopoietic stem cell transplantation in patients with X-linked hyper-IgM syndrome
Giorgia Bucciol, Sarah K Nicholas, Pier Luigi Calvo, et al.
Journal of Clinical Immunology
|
November 26, 2015
The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1
Mark Depner, Sebastian Fuchs, Jan Raabe, et al.
The World Allergy Organization Journal
|
April 3, 2019
X-linked agammaglobulinemia (XLA):Phenotype, diagnosis, and therapeutic challenges around the world
Zeinab A El-Sayed, Irina Abramova, Juan Carlos Aldave, et al.
The Journal of Allergy and Clinical Immunology
|
August 25, 2016
Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study
Tanya I Coulter, Anita Chandra, Chris M Bacon, et al.
Frontiers in Immunology
|
March 31, 2018
Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry
Maria Elena Maccari, Hassan Abolhassani, Asghar Aghamohammadi, et al.
Page
of 3